High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease

Bibliographic Details
Main Authors: Yan Li, Jinyong Zhang, Zilei Duan, Ning Wang, Xiangcheng Sun, Yanjing Zhang, Li Fu, Kaiyun Liu, Yongjun Yang, Shulei Pan, Yun Shi, Hao Zeng, Gang Guo, Ren Lai, Quanming Zou
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00763-5
id doaj-fa970316fb134b37a1db9a34e729c490
record_format Article
spelling doaj-fa970316fb134b37a1db9a34e729c4902021-10-03T11:13:02ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352021-09-01611310.1038/s41392-021-00763-5High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main proteaseYan Li0Jinyong Zhang1Zilei Duan2Ning Wang3Xiangcheng Sun4Yanjing Zhang5Li Fu6Kaiyun Liu7Yongjun Yang8Shulei Pan9Yun Shi10Hao Zeng11Gang Guo12Ren Lai13Quanming Zou14West China Biopharm Research Institute, West China Hospital, Sichuan UniversityNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical UniversityKey Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of SciencesWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityThe Research Core Facility, West China Hospital, Sichuan UniversityThe Research Core Facility, West China Hospital, Sichuan UniversityWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityMedical Research Center, Southwest Hospital, Army Medical UniversityWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical UniversityWest China Biopharm Research Institute, West China Hospital, Sichuan UniversityKey Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of SciencesNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical Universityhttps://doi.org/10.1038/s41392-021-00763-5
collection DOAJ
language English
format Article
sources DOAJ
author Yan Li
Jinyong Zhang
Zilei Duan
Ning Wang
Xiangcheng Sun
Yanjing Zhang
Li Fu
Kaiyun Liu
Yongjun Yang
Shulei Pan
Yun Shi
Hao Zeng
Gang Guo
Ren Lai
Quanming Zou
spellingShingle Yan Li
Jinyong Zhang
Zilei Duan
Ning Wang
Xiangcheng Sun
Yanjing Zhang
Li Fu
Kaiyun Liu
Yongjun Yang
Shulei Pan
Yun Shi
Hao Zeng
Gang Guo
Ren Lai
Quanming Zou
High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
Signal Transduction and Targeted Therapy
author_facet Yan Li
Jinyong Zhang
Zilei Duan
Ning Wang
Xiangcheng Sun
Yanjing Zhang
Li Fu
Kaiyun Liu
Yongjun Yang
Shulei Pan
Yun Shi
Hao Zeng
Gang Guo
Ren Lai
Quanming Zou
author_sort Yan Li
title High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
title_short High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
title_full High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
title_fullStr High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
title_full_unstemmed High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
title_sort high-throughput screening and evaluation of repurposed drugs targeting the sars-cov-2 main protease
publisher Nature Publishing Group
series Signal Transduction and Targeted Therapy
issn 2059-3635
publishDate 2021-09-01
url https://doi.org/10.1038/s41392-021-00763-5
work_keys_str_mv AT yanli highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT jinyongzhang highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT zileiduan highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT ningwang highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT xiangchengsun highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT yanjingzhang highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT lifu highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT kaiyunliu highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT yongjunyang highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT shuleipan highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT yunshi highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT haozeng highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT gangguo highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT renlai highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
AT quanmingzou highthroughputscreeningandevaluationofrepurposeddrugstargetingthesarscov2mainprotease
_version_ 1716845621472657408